![]() |
||
CrystaLaser Lasers in the Early Optogenetics Research Honored by the 2026 Nobel PrizeOctober 2026 · CrystaLaser, Reno, Nevada
On October 5, 2026, the Nobel Assembly at Karolinska Institutet awarded the
2026 Nobel Prize in Physiology or Medicine
to Karl Deisseroth, Peter Hegemann and Georg Nagel for their work on light-gated ion channels and optogenetics.
Several of the Deisseroth laboratory's early papers (2007–2010), which took optogenetics from the cell dish into living animals, name CrystaLaser as the maker of the 473 nm blue and 561 nm yellow fiber-coupled lasers used in the experiments.
Optogenetics and the Light-Source Problem
CrystaLaser compact DPSS laser heads with FC fiber coupling (product photo). The early papers describe this type of setup: a 473 nm laser coupled into a multimode optical fiber.
Optogenetics puts light-sensitive proteins from algae and microbes into chosen nerve cells. Channelrhodopsin-2 (ChR2), discovered by Nagel and Hegemann, switches neurons on with blue light. Halorhodopsin (NpHR) switches them off with yellow light. Light can then control those cells with millisecond timing. The first demonstration in cultured neurons (Boyden et al., 2005) used a filtered 300 W xenon arc lamp on a microscope. To control deep brain structures in a living, freely moving animal, the researchers needed a source that was bright, stable, could be switched in milliseconds, and could be coupled efficiently into a fiber thin enough to implant. Compact diode-pumped solid-state (DPSS) lasers with a TEM00 beam and fiber output met those needs. The Nobel Committee's scientific background describes this step:
CrystaLaser in the Published RecordThe Methods sections and figure legends of the papers below name CrystaLaser as the laser source. The quotes are taken from the published text.
Other laboratories adopted the same approach. For example, Haubensak et al. (Nature, 2010) and Brown et al. (PLoS One, 2010) also report CrystaLaser 473 nm lasers for in vivo stimulation. CrystaLaser's ContributionBetween 2005 and 2007, when optogenetics was a new, unproven idea, CrystaLaser supplied blue DPSS lasers with fiber coupling to Dr. Deisseroth's group at Stanford University. Those lasers were used in the work that first brought light-based control of neurons into the living brain. The 2010 Nature Protocols paper later listed the CrystaLaser BCL-473-050 by catalog number as the recommended light source, and laboratories around the world built their optogenetics setups from that protocol. Lasers for Optogenetics TodayCrystaLaser still designs and builds compact DPSS lasers for neuroscience in Reno, Nevada:
For an optogenetics configuration, use the information request form and include the wavelength, fiber core and NA, the power needed at the fiber tip, and the modulation scheme. References
The quotations above are from the cited publications and appear here for reference. CrystaLaser is not affiliated with the Nobel Foundation or Nobel Prize Outreach, and this page does not suggest that the Nobel laureates or their institutions endorse CrystaLaser. Nobel Prize® is a registered trademark of the Nobel Foundation. The product photo shows current CrystaLaser fiber-coupled lasers and is not an image from the cited papers. Related pages: Blue lasers | Yellow lasers | Fiber-coupled lasers | Laser combiners
* For more information, please access the online Information Request Form and download catalog.
|
|
© Copyright CrystaLaser 2017 All Rights Reserved |